B-cell targeted therapy alone may not be effective in bullous pemphigoid
Authors:
- 27 September 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 32 (1) , 111-112
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Long-standing remission of recalcitrant juvenile pemphigus vulgaris after adjuvant therapy with rituximabBritish Journal of Dermatology, 2005
- The Biology of CD20 and Its Potential as a Target for mAb Therapy2004
- Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host diseaseBone Marrow Transplantation, 2002
- Retention of B-cell-specific monoclonal antibodies by human lymphoma cellsBlood, 1994